FDA issues draft guidances targeting GERD-related conditions
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsGuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyRegulatory strategySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)